The LIVESTRONG Cancer Institutes of the Dell Medical School to Present at Clinical Congress 2019

Title of the panel: Reading Between the (Guide)-Lines: Can Real-World Survival Data Identify Patients Whose Survival Isn’t Improved by Guidelines-Based Treatments?

AUSTIN, TEXAS August 14, 2019

POTENTIAMETRICS, an Austin, TX-based healthcare data and analytics company, has been selected by the Employer Health Innovation Roundtable (EHIR) to present to 60 of the nation’s biggest employers uniting to fight the healthcare status quo.

PotentiaMetrics was selected from a pool of more than 200 innovator submissions as one of the top 10 innovators to present at the fall 2019 EHIR meeting Cohorts 1 (hosted by Best Buy) and 3 (hosted by The Home Depot).

Employer Health Innovation Roundtable (EHIR) is a coalition of the largest and most progressive employers committed to accelerating the adoption of innovation and improving employee health, wellness, and productivity. EHIR has been providing a streamlined innovation process and valuable insights to leading employers for the last 5 years.

“We are honored to be selected to present our MyCancerJourney platform to some of the largest and most innovative employers in the country,” says Robert Palmer, CEO of PotentiaMetrics.

About PotentiaMetrics 
PotentiaMetrics develops unique outcomes and insights solutions to support more informed, value-based treatment decisions that lead to better outcomes and reduced costs.

To learn more about PotentiaMetrics, visit: http://www.potentiametrics.com 
To learn more about MyCancerJourney, visit: http://www.mycancerjourney.com

AUSTIN, TEXAS (PRWEB) OCTOBER 22, 2018

PotentiaMetrics, an Austin, Texas, based healthcare data and artificial intelligence company, announced it has partnered with OptiMed Specialty Pharmacy to launch MyCancerJourney, a shared decision-making platform for cancer treatments.

MyCancerJourney was developed by researchers at Washington University School of Medicine in St. Louis to provide patient-specific survival estimates and improve cancer patient outcomes.

OptiMed’s clients will be able to enhance the value of their oncology care by offering this personalized medical information platform for their patients. Patients will have the ability to make better decisions with their healthcare providers and have a better experience with their cancer treatment journey.

“We’re excited to include this innovative platform (MyCancerJourney) to our arsenal of tools used to improve patient outcomes and add value to the healthcare ecosystem. I have seen a lot of analytical and AI healthcare solutions but MyCancerJourney is one of the very few solutions that lives up to the hype,” says OptiMed CEO Andy Reeves.

“We are thrilled to work alongside OptiMed. Both of our companies are focused on personalized approaches to healthcare that lead to improved outcomes and better value. Together we will provide the personalized information to patients and address the high-cost of cancer treatment in a meaningful way,” says Robert Palmer, CEO of PotentiaMetrics.

About PotentiaMetrics

PotentiaMetrics develops unique outcomes and insights solutions to support more informed, value-based treatment decisions that lead to better outcomes and reduced costs.

To learn more about PotentiaMetrics, visit: http://www.potentiametrics.com 
To learn more about MyCancerJourney, visit: http://www.mycancerjourney.com

About OptiMed Specialty Pharmacy

OptiMed Specialty Pharmacy, based in Kalamazoo, Michigan; is dually accredited by the Accreditation Commission for Health Care (ACHC) and URAC, specializes in treatments for rare and chronic conditions, such as rheumatoid arthritis, psoriasis, multiple sclerosis, oncology, and more. The organization has decades of experience offering personalized solutions that bring meaningful value to stakeholders.

To learn more about OptiMed Specialty Pharmacy, visit: http://www.optimedspecialtyrx.com

  Resources

Posted by PotentiaMetrics

AUSTIN, TEXAS (PRWEB) MARCH 18, 2019

POTENTIAMETRICS, an Austin, TX-based healthcare data and analytics company, announced the formation of The MyCancerJourney Clinical Advisory Board (CAB).

“We are pleased to commission the CAB and begin work to deploy the MyCancerJourney platform to improve outcomes for patients with cancer, enhance quality of life and lower costs significantly for patients, self-insured employers and the U.S. healthcare system”, noted Kendall Qualls, Chief Commercial Officer for PotentiaMetrics. He continued by saying, “over the next several weeks we’ll introduce the stellar group of physicians, surgeons, researchers that were eager to join our efforts to empower and dramatically change how patients with cancer make decisions about their treatment.

About PotentiaMetrics 
PotentiaMetrics develops unique outcomes and insights solutions to support more informed, value-based treatment decisions that lead to better outcomes and reduced costs.

To learn more about PotentiaMetrics, visit: http://www.potentiametrics.com 
To learn more about MyCancerJourney, visit: http://www.mycancerjourney.com